Semi Leadership Intact

Well folks, they never make it easy do they?  As of now the SOX is firm as apparently the Intel hype could not break the chart (though it did put a dent in it with the downside over throw).   I had been holding a preferred chip company through what was a paper loss yesterday,…

Central Banks Have Shot Their Wad – Why The Casino Is In Fo

There has been a lot of chatter in recent days about the plunge in commodity prices—–capped off by this week’s slide of the Bloomberg commodity index to levels not seen since 2002. That epochal development is captured in the chart below, but most of the media gumming about the rapidly accelerating “commodity crunch” misses the essential point. To wit,…

E

Shares of Inotek (ITEK) are up 52% after the company announced an end of phase 2 meeting with the FDA for its drug candidate known as Trabodenoson. Trabodenoson is used to treat patients with Glaucoma — a disease that causes blindness but can be avoided with early treatment. This drug works in glaucoma patients by…

URI Analysis

United Rentals (URI), shown below, is very typical of the kind of chart I’m short right now. It’s got a big top, very little in the way of support, and has demonstrated in prior years its ability to fall hard. This one is going to play out nicely today, as its indicated opening is where…

Bristol-Myers (BMY) Beats On Q2 Earnings, Updates View

Bristol-Myers Squibb Company (BMY – Analyst Report) is a major producer and distributor of pharmaceuticals and other healthcare related products. New York-based Bristol-Myers manufactures and sells branded pharmaceutical drugs such as Baraclude for hepatitis B virus (HBV), Sustiva for HIV and Erbitux for cancer. However, like many of its peers, Bristol-Myers is facing generic competition for several…